Skip to main content

Paul Newhouse Archives

Taylor, Newhouse, Petrie honored by geriatric psychiatry association

Apr. 21, 2022—Vanderbilt's Warren Taylor, MD, MHSc, Paul Newhouse, MD, and William Petrie, MD, were recently honored at the 2022 American Association for Geriatric Psychiatry (AAGP) Awards.

Read more


Vanderbilt Kennedy Center to host Jan. 25 workshop on Down syndrome and Alzheimer’s disease

Jan. 5, 2022—The Vanderbilt Kennedy Center is teaming up with the Down Syndrome Association of Middle Tennessee to host a virtual workshop on “Risks of Alzheimer’s Disease in Adults with Down Syndrome and Introduction to a Research Study.” The discussion will take place Tuesday, Jan. 25, from 2-3 p.m. CST. Click here to register Down syndrome, or...

Read more


Mood and cognition after chemotherapy

Jul. 26, 2021—Validation of cognitive complaints appears to improve mood in patients with persistent chemotherapy-cognitive impairment, Vanderbilt researchers report.

Read more


Study explores nicotine patch to treat late-life depression

Oct. 15, 2020—Backed by nearly $5 million in funding, researchers from Vanderbilt University Medical Center are testing to see whether transdermal nicotine patches can improve mood, forgetfulness and attentiveness in adults over 60 with a diagnosis of depression.

Read more


Memory complaints linked to changes in brain structure in postmenopausal women

Jul. 30, 2020—Memory complaints in younger postmenopausal women are associated with differences in brain structure and may serve as an early marker for risk of future cognitive decline, according to a study published June 22 in Menopause by Vanderbilt University Medical Center researchers.

Read more


Study seeks link between menopause, Alzheimer’s

Feb. 12, 2020—Beginning this month, researchers from VUMC and the University of Vermont are launching a study to examine whether cognitive changes that occur at menopause for some women are related to an increased risk for Alzheimer's disease.

Read more


Study explores nicotine patch to treat mild cognitive impairment

Nov. 2, 2017—Three years ago Reece Dean, of Nashville’s Bellevue community, retired at age 69 from a career as a busy truck driver. Mary Ann, his wife, began to notice some changes in his memory and behavior since he was home more consistently.

Read more


Vanderbilt begins Phase 1 trials of new Alzheimer’s drug

Aug. 7, 2017—Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.

Read more


Clues found to recurrent depression

Mar. 2, 2017—Women who have had repeated depressive episodes tend to pay more attention to negative emotional information, suggesting that they may benefit from cognitive therapy to build new, more positive pathways in their brains.

Read more


Investigational new drug for Alzheimer’s scheduled for first study in humans

Dec. 27, 2016—Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer's disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.

Read more


Study explores nicotine patch to treat memory loss

Oct. 29, 2015—Vanderbilt University Medical Center has received a $9.4 million grant from the National Institute on Aging (NIA) to test the effectiveness of a transdermal nicotine patch in improving memory loss in older adults with mild cognitive impairment (MCI), a precursor to Alzheimer’s disease.

Read more


Cancer drug enhances cognition

Dec. 16, 2013—The breast cancer drug tamoxifen improves cognitive performance in post-menopausal women.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more